A Clinical Trial of TQB3117 Tablets in Patients With Advanced Malignant Cancer

Clinical trial NCT06415903 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06415903
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Cancer

Start date: 2024-06-01
Primary completion: 2025-06-01
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.